Please use this identifier to cite or link to this item:
Title: Artificial neural network for predicting depressive symptoms in women with positive Papanicolaou smear results before and after diagnostic procedures
Authors: Ilic, Milena
Nedeljković B.
Jakovljevic V.
Ilic, Irena
Journal: SAMI 2020 - IEEE 18th World Symposium on Applied Machine Intelligence and Informatics, Proceedings
Issue Date: 1-Jan-2020
Abstract: © 2020 IEEE. In cervical cancer screening, depression is one of the most common causes of withdrawal from follow-up among women with abnormal Papanicolaou smear results. Various factors are responsible for depression among them. The purpose of this work was to predict depression among women with abnormal Papanicolaou smear results before and after diagnostic procedures using Artificial Neural Network (ANN) models. An epidemiological analytical observational study concerning the factors related to depression was carried out during 2017 in a cohort of women (N=172) with positive Papanicolaou screening test before and after diagnostic procedures (colposcopy/biopsy/endocervical curettage/cervical excision) in Clinical Centre Kragujevac, Serbia. Women completed the socio-demographic questionnaires which asked about basic characteristics (age, place of residence, education level, occupation, marital status) and questionnaire concerning depression (Hospital Anxiety and Depression Scale - HADS) right before the diagnostic procedures and 2-4 weeks after the diagnostic procedures, but before receiving definitive results. Multilayer perceptron was the applied binary classifier for predicting depression. Attribute selection showed that relevant attributes for predicting depression before diagnostic procedures were use of sedatives, 'Worry' score on POSM scale, CESD-depression score and HADS-anxiety score. For depression after diagnostic procedures, predictors included the place of residence, CESD-depression score and HADS-anxiety score. Results of this research enable timely psychological support of women with positive cervical screening test, and that way enable greater coverage of diagnostic procedures and timely treatment, which will reduce complications and death.
Type: Conference Paper
DOI: 10.1109/SAMI48414.2020.9108722
SCOPUS: 85087091862
Appears in Collections:University Library, Kragujevac
[ Google Scholar ]

Page views(s)




Files in This Item:
File Description SizeFormat 
  Restricted Access
29.86 kBAdobe PDFThumbnail

Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.